The Induction by Topical Minoxidil of Increased Fenestration in the Perifollicular Capillary Wall

Minoxidil was applied to a single miniaturized hair follicle over four months, resulting in less miniaturization but not yet terminal growth. The user used a 5% minoxidil solution, specifically the Regaine brand, and observed changes using a handheld WiFi microscope.

Topical finasteride combined with minoxidil is used for hair loss treatment, with some users experiencing fewer side effects compared to oral finasteride. Morr-F, a topical solution, shows better results than minoxidil alone, with minimal adverse effects reported.

The user experienced stable hairline but diffuse thinning after switching from oral finasteride to a topical solution of minoxidil and finasteride. They are concerned about the effectiveness of the topical treatment and are considering other options due to a recent decline in hair density.

Minoxidil 5% was used twice daily, leading to hair regrowth and increased density. The user plans to switch to oral minoxidil and finasteride, but currently uses a topical solution with 0.1% finasteride.

The user experienced side effects from oral minoxidil, such as palpitations and insomnia, and switched to topical minoxidil, which led to noticeable hair regrowth, especially at the hairline. They also use finasteride and observed increased hair shedding initially, which later stabilized.

A 30-year-old is using oral finasteride 1mg daily, topical minoxidil 5% twice a day, dermastamping, Nizoral shampoo, and supplements for hair regrowth. They report positive results and plan to update with longer hair in the future.